Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Accenture
Federal Trade Commission
Deloitte
Citi
Julphar
Dow
McKinsey
Moodys

Generated: September 18, 2018

DrugPatentWatch Database Preview

Anacor Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ANACOR PHARMS INC, and what generic alternatives to ANACOR PHARMS INC drugs are available?

ANACOR PHARMS INC has two approved drugs.

There are nine US patents protecting ANACOR PHARMS INC drugs.

Summary for Anacor Pharms Inc
US Patents:9
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Anacor Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes 7,582,621*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes 9,566,289*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes 9,566,290*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes 9,682,092 ➤ Try a Free Trial ➤ Try a Free Trial
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Anacor Pharms Inc EUCRISA crisaborole OINTMENT;TOPICAL 207695-001 Dec 14, 2016 RX Yes Yes 8,501,712 ➤ Try a Free Trial ➤ Try a Free Trial
Anacor Pharms Inc KERYDIN tavaborole SOLUTION;TOPICAL 204427-001 Jul 7, 2014 RX Yes Yes 9,572,823*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for Anacor Pharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,767,657 Boron-containing small molecules ➤ Try a Free Trial
8,889,656 Boron-containing small molecules ➤ Try a Free Trial
8,722,917 Boron-containing small molecules ➤ Try a Free Trial
9,029,353 Boron-containing small molecules as anti-inflammatory agents ➤ Try a Free Trial
8,440,642 Boron-containing small molecules ➤ Try a Free Trial
8,115,026 Boron-containing small molecules ➤ Try a Free Trial
9,353,133 Boron-containing small molecules ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Anacor Pharms Inc Drugs

Country Document Number Estimated Expiration
Australia 2010203096 ➤ Try a Free Trial
China 101914109 ➤ Try a Free Trial
Israel 192402 ➤ Try a Free Trial
Canada 2933994 ➤ Try a Free Trial
South Korea 20080110984 ➤ Try a Free Trial
Russian Federation 2642628 ➤ Try a Free Trial
Spain 2414095 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
Fish and Richardson
Queensland Health
Cerilliant
Chubb
Dow
Baxter
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.